@misc{indiciae6d78542a6e00,
  title = {Epigenetic-focused CRISPR/Cas9 screen identifies ASH2L as a regulator of glioblastoma cell survival},
  author = {Ozyerli-Goknar, E. and Kala, E. Y. and Aksu, A. C. and Bulut, I. and Cingoz, A. and Nizamuddin, S. and Biniossek, M. and Seker-Polat, F. and Morova, T. and Aztekin, C. and Kung, S. H. A. and Syed, H. and Tuncbag, N. and Gonen, M. and Philpott, M. and Cribbs, A. P. and Acilan, C. and Lack, N. A. and Onder, T. T. and Timmers, H. T. M. and Bagci-Onder, T.},
  year = {2022},
  doi = {10.1101/2022.08.17.504245},
  url = {https://www.biorxiv.org/content/10.1101/2022.08.17.504245v1},
  note = {Source identifier: 10.1101/2022.08.17.504245}
}